CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells
Wei, Chaogang, Wang, Fengjiao, Liu, Wei, Zhao, Wenlu, Yang, Yi, Li, Kai, Xiao, Li, Shen, JunkangLanguage:
english
Journal:
Molecular Medicine Reports
DOI:
10.3892/mmr.2017.8257
Date:
December, 2017
File:
PDF, 1.38 MB
english, 2017